
    
      Each individual enter into this project will receive regulate treatment adding-on memantine
      medication. During each visit, patients will receive evaluation for their symptoms and plasma
      Brain-Derived Neurotropic Factor (BDNF), cytokines (e.g.., Interleukin-6(IL-6), IL-8) and
      neuropsychological performance.
    
  